Experimental infection of non-human primates with a human rotavirus isolate. (Q54683656)

2 June 2018

title

Experimental infection of non-human primates with a human rotavirus isolate. (English)

1 reference

2 June 2018

main subject

experimental infection

1 reference

Gerald K Chege

1

1 reference

2 June 2018

A D Steele

2

1 reference

2 June 2018

C A Hart

3

1 reference

2 June 2018

D R Snodgrass

4

1 reference

2 June 2018

Erick O Omolo

5

1 reference

2 June 2018

Jason M Mwenda

6

1 reference

2 June 2018

language of work or name

English

0 references

publication date

1 February 2005

1 reference

2 June 2018

published in

Vaccine

1 reference

2 June 2018

volume

23

1 reference

2 June 2018

issue

12

1 reference

2 June 2018

page(s)

1522-1528

1 reference

2 June 2018

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

1 reference

Development of candidate rotavirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

Rotavirus vaccines: an overview.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

Safety, Immunogenicity, and Protective Efficacy of One and Three Doses of the Tetravalent Rhesus Rotavirus Vaccine in Infants in Lima, Peru

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

[Anti-rotavirus vaccinations]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

Rotavirus infections: guidelines for treatment and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

Rotavirus infection in African, non-human primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

Stimulation of rotavirus IgA, IgG and neutralising antibodies in baboon milk by parenteral vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

The relative frequency of subgroup I and II rotaviruses in black infants in South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

Experimental group A rotaviral infection in cynomolgus monkeys raised on formula diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

Diarrhea in newborn cynomolgus monkeys infected with human rotavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

Molecular epidemiology of rotavirus in black infants in South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

7 January 2021

Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

7 January 2021

Identification of group A rotavirus gene 4 types by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

7 January 2021

A murine model for oral infection with a primate rotavirus (simian SA11)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.055

7 January 2021

10.1016/J.VACCINE.2004.06.055

Identifiers

DOI

1 reference

2 June 2018

1 reference

2 June 2018